<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="iso-def" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">iso-def</book-part-id>
      <title-group>
        <title>Isolated Sulfite Oxidase Deficiency</title>
        <alt-title alt-title-type="alt-title">Synonym: Sulfocysteinuria</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bindu</surname>
            <given-names>Parayil Sankaran</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <xref ref-type="aff" rid="iso-def.Tc.aff1"/>
          <email>drpsbindu@yahoo.co.in</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nagappa</surname>
            <given-names>Madhu</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <xref ref-type="aff" rid="iso-def.Tc.aff1"/>
          <email>madhu_nagappa@yahoo.co.in</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bharath</surname>
            <given-names>Rose Dawn</given-names>
          </name>
          <degrees>DM</degrees>
          <xref ref-type="aff" rid="iso-def.Tc.aff2"/>
          <email>drrosedawn@yahoo.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Taly</surname>
            <given-names>Arun B</given-names>
          </name>
          <degrees>MD, DM</degrees>
          <xref ref-type="aff" rid="iso-def.Tc.aff2"/>
          <email>abtaly@yahoo.com</email>
        </contrib>
      </contrib-group>
      <aff id="iso-def.Tc.aff1">Department of Neurology<break/>National Institute of Mental Health and Neurosciences<break/>Bangalore, India</aff>
      <aff id="iso-def.Tc.aff2">Department of Neuroimaging and Interventional Neuroradiology<break/>National Institute of Mental Health and Neurosciences<break/>Bangalore, India</aff>
      <pub-history>
        <date date-type="created">
          <day>21</day>
          <month>9</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="mma" document-type="chapter">Isolated Methylmalonic Acidemia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="jln" document-type="chapter">Jervell and Lange-Nielsen Syndrome</related-object>
      <abstract id="iso-def.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The spectrum of isolated sulfite oxidase deficiency ranges from classic early-onset (severe) disease to late-onset (mild) disease.</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">Classic ISOD</italic> is characterized in the first few hours to days of life by intractable seizures, feeding difficulties, and rapidly progressive encephalopathy manifest as abnormal tone (especially opisthotonus, spastic quadriplegia, and pyramidal signs) followed by progressive microcephaly and profound intellectual disability. Lens subluxation or dislocation, another characteristic finding, may be evident after the newborn period. Children usually die during the first few months of life.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">Late-onset ISOD</italic> manifests between ages six and 18 months and is characterized by ectopia lentis (variably present), developmental delay/regression, movement disorder characterized by dystonia and choreoathetosis, ataxia, and (rarely) acute hemiplegia due to metabolic stroke. The clinical course may be progressive or episodic. In the episodic form encephalopathy, dystonia, choreoathetosis, and/or ataxia are intermittent.</p>
            </list-item>
          </list>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Laboratory findings that suggest the diagnosis of ISOD are dipstick positive for urinary sulfite, elevated urinary thiosulfate and S-sulfocysteine, low urinary organic sulfate, and markedly reduced plasma levels of total homocysteine. The diagnosis is confirmed by identification of biallelic pathogenic variants in <italic toggle="yes">SUOX</italic> by molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> No treatment exists for the underlying metabolic defect. Symptomatic treatment can include: antiepileptic drugs (AEDs) for seizures; medications to reduce spasticity; and early consideration of gastrostomy tube placement to manage difficulties with swallowing, assure adequate caloric intake, and reduce risk of aspiration. Other measures can include vigorous chest physiotherapy to prevent respiratory complications. Treatment of vomiting, gastroesophageal reflux, and aspiration pneumonia are per routine.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic assessment by a multidisciplinary team with particular attention to nutritional status, neurologic status (to evaluate dosages of AEDs and their side effects), and degree of spasticity and related complications.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ISOD is inherited in an autosomal recessive manner. The parents of an affected child are asymptomatic obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SUOX</italic> pathogenic variant) and are not at risk of developing the disorder. Each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Once the <italic toggle="yes">SUOX</italic> pathogenic variants have been identified in an affected family member, carrier testing for at-risk relatives, prenatal testing for a pregnancy at increased risk, and preimplantation genetic diagnosis are possible.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="iso-def.Diagnosis">
        <title>Diagnosis</title>
        <sec id="iso-def.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><bold>Classic early-onset (severe) and late-onset (mild) isolated sulfite oxidase deficiency (ISOD)</bold>
<bold>should be suspected</bold> in infants with the following clinical, neuroimaging, and supportive laboratory findings.</p>
          <sec id="iso-def.Clinical_Features">
            <title>Clinical Features</title>
            <p>
              <bold>Classic ISOD</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Intractable seizures and feeding difficulties in the first few hours to days of life</p>
              </list-item>
              <list-item>
                <p>Progressive encephalopathy manifest as abnormal tone (especially opisthotonus, spastic quadriplegia, and pyramidal signs)</p>
              </list-item>
              <list-item>
                <p>Progressive microcephaly</p>
              </list-item>
              <list-item>
                <p>Profound intellectual disability</p>
              </list-item>
              <list-item>
                <p>Dysmorphic facial features: long face, narrow bifrontal diameter, deep and widely set eyes, elongated palpebral fissures, puffy cheeks, small nose, long philtrum, and thick lips (<xref ref-type="fig" rid="iso-def.F1">Figure 1</xref>) [<xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]</p>
              </list-item>
              <list-item>
                <p>Lens subluxation or dislocation (ectopia lentis) after the newborn period</p>
              </list-item>
              <list-item>
                <p>Family history consistent with autosomal recessive inheritance</p>
              </list-item>
            </list>
            <p>
              <bold>Late-onset ISOD</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Onset usually between age six and 18 months, often precipitated by febrile illness</p>
              </list-item>
              <list-item>
                <p>Ectopia lentis (variably present)</p>
              </list-item>
              <list-item>
                <p>Developmental regression</p>
              </list-item>
              <list-item>
                <p>Episodic encephalopathy, ataxia, choreoathetosis, and dystonia</p>
              </list-item>
              <list-item>
                <p>Acute hemiparesis due to metabolic stroke</p>
              </list-item>
            </list>
          </sec>
          <sec id="iso-def.Neuroimaging_Findings">
            <title>Neuroimaging Findings</title>
            <p>
              <bold>Classic ISOD</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Cranial MRI</bold> resembles that of hypoxic-ischemic encephalopathy (<xref ref-type="fig" rid="iso-def.F2">Figure 2</xref>) in the following manner [<xref ref-type="bibr" rid="iso-def.REF.rupar.1996.299">Rupar et al 1996</xref>, <xref ref-type="bibr" rid="iso-def.REF.tan.2005.757">Tan et al 2005</xref>, <xref ref-type="bibr" rid="iso-def.REF.basheer.2007.38">Basheer et al 2007</xref>, <xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>, <xref ref-type="bibr" rid="iso-def.REF.bindu.2011.1036">Bindu et al 2011</xref>, <xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>During the first week, loss of gray-white matter differentiation and edema in the cerebral cortex and basal ganglia</p>
                  </list-item>
                  <list-item>
                    <p>During the ensuing weeks, development of the following:</p>
                    <list list-type="bullet">
                      <list-item>
                        <p>Cystic encephalomalacia in the subcortical white matter, external capsules, and basal ganglia</p>
                      </list-item>
                      <list-item>
                        <p>Ventriculomegaly and diffuse cerebral atrophy, which may be consistent with ulegyria</p>
                      </list-item>
                      <list-item>
                        <p>Thinning of the corpus callosum</p>
                      </list-item>
                    </list>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>CT</bold> shows calcifications in thalami and/or basal ganglia [<xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>, <xref ref-type="bibr" rid="iso-def.REF.zaki.2016.714">Zaki et al 2016</xref>].</p>
                <p>Of note: Marked cerebellar hypoplasia and the progressive cystic and atrophic changes seen ISOD help differentiate it from mild-to-moderate hypoxic ischemic encephalopathy, in which the cerebellum, brain stem, and deep gray matter structures are usually spared [<xref ref-type="bibr" rid="iso-def.REF.volpe.2008">Volpe 2008</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Diffusion-weighted imaging</bold> shows diffuse and symmetric cytotoxic edema involving the basal ganglia, cerebral cortex, and subcortical white matter suggesting an acute metabolic derangement [<xref ref-type="bibr" rid="iso-def.REF.eichler.2006.801">Eichler et al 2006</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Magnetic resonance spectroscopy</bold> shows reduced N-acetylaspartate/total creatine ratio and abnormal elevation of lactate, glutamine, and glutamate peaks [<xref ref-type="bibr" rid="iso-def.REF.hoffmann.2007.1214">Hoffmann et al 2007</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Single-photon emission tomography</bold> using 99mTc-ethyl cysteinate dimer in one individual showed decreased uptake bilaterally in the frontal lobes [<xref ref-type="bibr" rid="iso-def.REF.huang.2012.44">Huang et al 2012</xref>].</p>
              </list-item>
            </list>
            <p>
              <bold>Late-onset ISOD</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Cranial MRI</bold> shows T<sub>2</sub>-weighted hyperintensities in the globus pallidi at presentation; thin corpus callosum is the other finding [<xref ref-type="bibr" rid="iso-def.REF.del_rizzo.2013.263">Del Rizzo et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.rocha.2014.176">Rocha et al 2014</xref>].</p>
              </list-item>
            </list>
          </sec>
          <sec id="iso-def.Laboratory_Findings">
            <title>Laboratory Findings</title>
            <p><bold>Both classic and late-onset ISOD</bold> exhibit a characteristic metabolic profile that includes the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>
                  <bold>Urinary sulfite identified on a dipstick screening test</bold>
                </p>
                <p>Note: (1) Urinary sulfite is very unstable and disappears rapidly from urine either at room temperature or even when urine is stored at 40&#x000b0; C; therefore, testing immediately after voiding is recommended [<xref ref-type="bibr" rid="iso-def.REF.johnson.2001">Johnson &#x00026; Duran 2001</xref>, <xref ref-type="bibr" rid="iso-def.REF.tan.2005.757">Tan et al 2005</xref>]. (2) False positive urinary sulfite results may be caused by:</p>
                <list list-type="bullet">
                  <list-item>
                    <p>Drugs containing free aliphatic sulfhydryl group such as N-acetyl cysteine, mercaptamine, dimercaprol, and mucolite drug 2-mercaptoethane sulfonate;</p>
                  </list-item>
                  <list-item>
                    <p>Certain antibiotics such as cefotaxime, cefuroxime, ampicillin, and benzylpenicillin [<xref ref-type="bibr" rid="iso-def.REF.tan.2005.757">Tan et al 2005</xref>]; and</p>
                  </list-item>
                  <list-item>
                    <p>Bacterial degradation of urine samples as reflected by increased levels of compounds such as succinic acid, benzoic acid, 2-hydroxyglutaric acid, and uracil [<xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>].</p>
                  </list-item>
                </list>
              </list-item>
              <list-item>
                <p><bold>Elevated urinary thiosulfate and S-sulfocysteine and low urinary organic sulfate.</bold> Urinary thiosulfate, a stable compound, is measured by a spectrophotometric method. S-sulfocysteine is measured by tandem mass spectrometry [<xref ref-type="bibr" rid="iso-def.REF.rashed.2005.223">Rashed et al 2005</xref>, <xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>]. (Note that serum uric acid levels are normal &#x02012; as are urine xanthine and hypoxanthine levels.)</p>
              </list-item>
              <list-item>
                <p><bold>Markedly reduced plasma level of total homocysteine,</bold> a sensitive and specific indicator of sulfite oxidase deficiency [<xref ref-type="bibr" rid="iso-def.REF.basheer.2007.38">Basheer et al 2007</xref>, <xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>]</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="iso-def.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of ISOD <bold>is established</bold> in a proband by the identification of biallelic pathogenic variants in <italic toggle="yes">SUOX</italic> by molecular genetic testing (see <xref ref-type="table" rid="iso-def.T.molecular_genetic_testing_used">Table 1</xref>).</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (single-gene testing or a multi-gene panel) and <bold>genomic testing</bold> (comprehensive genomic sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not. Because the phenotype of isolated sulfite oxidase deficiency is broad, children with the distinctive findings of classic ISOD described in <xref ref-type="sec" rid="iso-def.Suggestive_Findings">Suggestive Findings</xref> are likely to be diagnosed using gene-targeted testing (see <xref ref-type="sec" rid="iso-def.Option_1">Option 1</xref>), whereas those with a phenotype indistinguishable from many other inherited neonatal seizures or those with late-onset (milder) ISOD are more likely to be diagnosed using genomic testing (see <xref ref-type="sec" rid="iso-def.Option_2">Option 2</xref>).</p>
          <sec id="iso-def.Option_1">
            <title>Option 1</title>
            <p>When the phenotypic and laboratory findings suggest the diagnosis of ISOD, molecular genetic testing approaches can include <bold>single-gene testing</bold> or use of a <bold>multi-gene panel</bold>:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">SUOX</italic> is performed first. If only one pathogenic variant is found, gene-targeted deletion/duplication analysis could be considered; however, to date no exonic or whole gene deletions have been reported.</p>
              </list-item>
              <list-item>
                <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">SUOX</italic> and other genes of interest (see <xref ref-type="sec" rid="iso-def.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting secondary findings. Of note, given the rarity of isolated sulfite oxidase deficiency many panels for neonatal seizures may not include this gene. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
                <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
              </list-item>
            </list>
          </sec>
          <sec id="iso-def.Option_2">
            <title>Option 2</title>
            <p>When the phenotype is indistinguishable from many other inherited neonatal seizures, molecular genetic testing approaches can include <bold>genomic testing</bold> and/or <bold>gene-targeted testing</bold>:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Comprehensive genome sequencing</bold> (when clinically available) includes exome sequencing and genome sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
              </list-item>
              <list-item>
                <p><bold>A neonatal epileptic encephalopathy multi-gene panel</bold> may be considered.</p>
              </list-item>
            </list>
            <table-wrap id="iso-def.T.molecular_genetic_testing_used" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in Isolated Sulfite Oxidase Deficiency</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">SUOX</italic>
                    </td>
                    <td headers="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">All variants reported to date have been identified by sequence analysis.</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                    <td headers="hd_h_iso-def.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="iso-def.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="iso-def" object-id="iso-def.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="iso-def.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="iso-def.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="iso-def.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="iso-def.TF.1.4">
                  <label>4. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="iso-def.TF.1.5">
                  <label>5. </label>
                  <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="iso-def.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="iso-def.Clinical_Description">
          <title>Clinical Description</title>
          <p>Isolated sulfite oxidase deficiency (ISOD), a rare inborn error of metabolism of sulfur-containing amino acids, comprises a spectrum ranging from classic early-onset (severe) disease to late-onset (mild) disease [<xref ref-type="bibr" rid="iso-def.REF.johnson.2001">Johnson &#x00026; Duran 2001</xref>].</p>
          <sec id="iso-def.Classic_ISOD">
            <title>Classic ISOD</title>
            <p>Classic ISOD typically manifests within few hours to days of life with intractable seizures, feeding difficulties, and rapidly progressive encephalopathy [<xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>, <xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]. The clinical features resemble that of neonatal hypoxic ischemic encephalopathy.</p>
            <p>Almost all affected infants are born after uncomplicated pregnancy. Of note, sustained abdominal trembling resembling vibration of mobile phones (interpreted as fetal seizures) has been reported in the third trimester in one instance [<xref ref-type="bibr" rid="iso-def.REF.chen.2014.181">Chen et al 2014</xref>]. Delivery is usually uncomplicated, although Apgar scores may be depressed.</p>
            <p>Multiple types of seizures including tonic-clonic and multifocal myoclonic seizures not responding to treatment are the main feature [<xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>, <xref ref-type="bibr" rid="iso-def.REF.bindu.2011.1036">Bindu et al 2011</xref>, <xref ref-type="bibr" rid="iso-def.REF.salih.2013.109">Salih et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]. Rarely, infantile spasms and hypsarrhythmia, exaggerated startle response, or hyperekplexia also have been reported [<xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>, <xref ref-type="bibr" rid="iso-def.REF.holder.2014.782">Holder et al 2014</xref>]. Electroencephalography (EEG) shows low-amplitude or disorganized background [<xref ref-type="bibr" rid="iso-def.REF.sass.2010.544">Sass et al 2010</xref>, <xref ref-type="bibr" rid="iso-def.REF.holder.2014.782">Holder et al 2014</xref>], multifocal epileptiform discharges [<xref ref-type="bibr" rid="iso-def.REF.holder.2014.782">Holder et al 2014</xref>], or a burst suppression pattern [<xref ref-type="bibr" rid="iso-def.REF.relinque.2015.53">Relinque et al 2015</xref>].</p>
            <p>Neurologic examination reveals abnormalities in tone including opisthotonus, spastic quadriplegia, and pyramidal signs.</p>
            <p>All affected children develop profound psychomotor retardation: neurologic development is halted at the level of brain stem reflexes and children lack any response to environmental stimulation except for exaggerated startle and intermittent seizures [<xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>].</p>
            <p>Although head circumference is normal at birth, severe progressive postnatal microcephaly develops [<xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]. Progressive facial dysmorphism is an additional feature.</p>
            <p>Systemic manifestations are rare and can include such findings as severe asthma and pyloric stenosis [<xref ref-type="bibr" rid="iso-def.REF.bindu.2011.1036">Bindu et al 2011</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>].</p>
            <p>Prognosis is poor and children usually die during the first few months of life.</p>
            <p>A significant proportion of infants who survive the newborn period develop ectopia lentis (lens dislocation or subluxation) [<xref ref-type="bibr" rid="iso-def.REF.johnson.2001">Johnson &#x00026; Duran 2001</xref>, <xref ref-type="bibr" rid="iso-def.REF.bosley.2014.42">Bosley et al 2014</xref>]. The natural history of ectopia lentis is not known: it may not be present (or at least not obvious) during the first few months and may only become evident (and detectable by ophthalmologic examination) during the first year. Subtle lens dislocation may be obvious only after dilatation of the pupil and slit lamp examination (over time) [<xref ref-type="bibr" rid="iso-def.REF.lueder.1995.334">Lueder &#x00026; Steiner 1995</xref>].</p>
          </sec>
          <sec id="iso-def.LateOnset_ISOD">
            <title>Late-Onset ISOD</title>
            <p>Late-onset ISOD differs from the classic form in that onset is between ages six and 18 months and some suggestive findings (e.g., intractable seizures, ectopia lentis) may be absent.</p>
            <p>The main clinical features are developmental delay/regression, movement disorder characterized by dystonia and choreoathetosis, ataxia, and (rarely) acute hemiplegia due to metabolic stroke. The clinical course may be progressive or episodic. In the episodic form encephalopathy, dystonia, choreoathetosis, and/or ataxia are intermittent [<xref ref-type="bibr" rid="iso-def.REF.van_der_knaap.2005">Van der Knaap &#x00026;Valk 2005</xref>, <xref ref-type="bibr" rid="iso-def.REF.del_rizzo.2013.263">Del Rizzo et al 2013</xref>, <xref ref-type="bibr" rid="iso-def.REF.rocha.2014.176">Rocha et al 2014</xref>].</p>
            <p>Ectopia lentis (lens dislocation or subluxation) may or may not be present at the time of presentation.</p>
          </sec>
        </sec>
        <sec id="iso-def.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>The number of individuals with confirmed pathogenic variants in <italic toggle="yes">SUOX</italic> is too small to make any conclusive genotype-phenotype correlations.</p>
        </sec>
        <sec id="iso-def.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of ISOD is unknown. Approximately 50 affected individuals have been reported to date. The disorder is probably underdiagnosed. The incidence may be higher in populations with a high rate of consanguinity.</p>
          <p>ISOD is pan ethnic.</p>
        </sec>
      </sec>
      <sec id="iso-def.Genetically_Related_Allelic_Diso">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">SUOX</italic>.</p>
      </sec>
      <sec id="iso-def.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <table-wrap id="iso-def.T.disorders_to_consider_in_the_d" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Disorders to Consider in the Differential Diagnosis of Isolated Sulfite Oxidase Deficiency (ISOD)</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1">Disorder</th>
                <th id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2">Gene(s)</th>
                <th id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3">MOI</th>
                <th id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4" valign="middle" colspan="2" align="center" scope="colgroup" rowspan="1">Features of This Disorder</th>
              </tr>
              <tr>
                <th headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Overlapping w/ISOD</th>
                <th headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4" id="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Distinguishing from ISOD</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Molybdenum cofactor deficiency<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/PS252150">PS252150</ext-link>)</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">MOCS1</italic>
                  <break/>
                  <italic toggle="yes">MOCS2</italic>
                  <break/>
                  <italic toggle="yes">GPHN</italic>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Intractable seizures &#x00026; feeding difficulties in first few hours to days of life; subsequent severe ID, spasticity, &#x00026; seizures refractory to AEDs</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Low serum uric acid levels; elevated urinary xanthine &#x00026; hypoxanthine levels due to loss of function of xanthine dehydrogenase</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="nkh" document-type="chapter">Glycine encephalopathy</related-object>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">GLDC</italic>
                  <break/>
                  <italic toggle="yes">AMT</italic>
                  <break/>
                  <italic toggle="yes">GCSH</italic>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Progressive lethargy, hypotonia, &#x00026; myoclonic jerks in first few hours to days of life; subsequent profound ID &#x00026; seizures refractory to AEDs</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Elevated glycine levels in plasma &#x00026; CSF;<break/>On MRI: diffusion restriction of areas that are myelinating at birth (e.g., posterior limb of internal capsule &#x00026; pericentral area)</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                  <related-object link-type="booklink" source-id="gene" document-id="pds" document-type="chapter">Pyridoxine- dependent epilepsy</related-object>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">ALDH7A1</italic>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Soon after birth: seizures refractory to AEDs</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Seizures respond to large supplements of pyridoxine.</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pyridox(am)ine 5'-phosphate oxidase deficiency<break/>(OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://omim.org/entry/610090">610090</ext-link>)</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">
                  <italic toggle="yes">PNPO</italic>
                </td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Soon after birth: seizures refractory to AEDs &#x00026; pyridoxine</td>
                <td headers="hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_1_4 hd_h_iso-def.T.disorders_to_consider_in_the_d_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Seizures respond to pyridoxal-5&#x02019; phosphate.</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>ID = intellectual disability</p>
            </fn>
            <fn>
              <p>AEDs = antiepileptic drugs</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="iso-def.Management">
        <title>Management</title>
        <sec id="iso-def.Evaluations_Following_Initial_Di">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and/or needs in an indivudal with a diagnosis of isolated sulfite oxidase deficiency (ISOD), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Complete neurologic assessment by a pediatric neurologist</p>
            </list-item>
            <list-item>
              <p>Formal developmental assessment</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic evaluation</p>
            </list-item>
            <list-item>
              <p>EEG/video EEG to monitor seizures</p>
            </list-item>
            <list-item>
              <p>Assessment of feeding and nutrition and appropriate intervention</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="iso-def.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>To date, no definitive treatment for ISOD has been identified. Symptomatic management by a multidisciplinary team consisting of specialists in neurology, nutrition, gastroenterology, pulmonary medicine, physiotherapy, and orthopedics is recommended. Management includes the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Appropriate medications for management of seizures and spasticity</p>
            </list-item>
            <list-item>
              <p>Early consideration of gastrostomy tube placement to manage difficulties with swallowing to assure adequate caloric intake and reduce the risk of aspiration.</p>
            </list-item>
            <list-item>
              <p>Appropriate management of vomiting, gastroesophageal reflux disease, and aspiration pneumonia</p>
            </list-item>
            <list-item>
              <p>Chest physiotherapy to prevent respiratory complications</p>
            </list-item>
            <list-item>
              <p>Sleep studies to assess nocturnal hypoventilation and institute appropriate interventions</p>
            </list-item>
            <list-item>
              <p>Assessment for scoliosis</p>
            </list-item>
          </list>
          <p>The following treatment modalities have been tried with minimal success:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Dietary.</bold> A low-protein diet restricted in cysteine and methionine has been tried in a few individuals with ISOD. Clinical and biochemical improvement were reported in two patients with late-onset ISOD [<xref ref-type="bibr" rid="iso-def.REF.del_rizzo.2013.263">Del Rizzo et al 2013</xref>]. No clinical benefit has been noted in those with classic ISOD. The value of these diets in presymptomatic individuals has yet to be established.</p>
            </list-item>
            <list-item>
              <p><bold>Medical.</bold> No medical treatment that improves the neurologic outcome or prevents the development of neurologic manifestations in individuals with ISOD has been identified. The following agents have been tried on an experimental basis with minimal clinical effect:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Betaine has been used to increase the remethylation of homocysteine back to methionine, which reduces cysteine and leads to reduction in sulfite levels.</p>
                </list-item>
                <list-item>
                  <p>Thiamine replacement has been attempted (given that the accumulation of sulfite leads to depletion of thiamine).</p>
                </list-item>
                <list-item>
                  <p>Use of cysteamine and penicillamine (chelating agents used to chelate sulfite) resulted in no beneficial clinical effects.</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="iso-def.Surveillance">
          <title>Surveillance</title>
          <p>Periodic assessment by the multidisciplinary team with particular attention to the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Nutritional status</p>
            </list-item>
            <list-item>
              <p>Neurologic status including evaluation of dosages of antiepileptic drugs and their side effects</p>
            </list-item>
            <list-item>
              <p>Degree of spasticity and related complications, including scoliosis</p>
            </list-item>
            <list-item>
              <p>Periodic sleep studies</p>
            </list-item>
          </list>
        </sec>
        <sec id="iso-def.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="iso-def.Related_Genetic_Counseling_Issue">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="iso-def.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There many not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="iso-def.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="iso-def.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Isolated sulfite oxidase deficiency (ISOD) is inherited in an autosomal recessive manner.</p>
        </sec>
        <sec id="iso-def.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an affected child are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SUOX</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with isolated ISOD would be obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">SUOX</italic>. To date, no affected individuals have reproduced.</p>
          <p><bold>Other family members.</bold> Each sib of the proband&#x02019;s parents is at a 50% risk of being a carrier of a <italic toggle="yes">SUOX</italic> pathogenic variant.</p>
        </sec>
        <sec id="iso-def.Carrier_Heterozygote_Detection">
          <title>Carrier (Heterozygote) Detection</title>
          <p>Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">SUOX</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="iso-def.Related_Genetic_Counseling_Issue">
          <title>Related Genetic Counseling Issues</title>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="iso-def.Prenatal_Testing_and_Preimplanta">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SUOX</italic> pathogenic variants have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="iso-def.Resources">
        <title>Resources</title>
      </sec>
      <sec id="iso-def.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The longest <italic toggle="yes">SUOX</italic> transcript (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000456.2">NM_000456.2</ext-link>) comprises eight exons distributed over 2.5 kb. This is the sequence typically analyzed by standard screening.</p>
        <p>See <related-object source-id="gene" document-id="iso-def" object-id="iso-def.molgen.TA">Table A</related-object>, <bold>Gene</bold> for a detailed summary of gene and protein information.</p>
        <p><bold>Pathogenic variants.</bold> The variants identified in <italic toggle="yes">SUOX</italic> include deletions, insertions, and missense variants.</p>
        <p>An individual with uniparental disomy 12 (UPD12) with a paternal p.Tyr400Ter reduced to homozygosity has been reported [<xref ref-type="bibr" rid="iso-def.REF.cho.2013.13">Cho et al 2013</xref>].</p>
        <table-wrap id="iso-def.T.selected_suox_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">SUOX</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">Reference Sequence</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">See footnote 1</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Ser427Tyr</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_3" rowspan="2" valign="top" align="left" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.520delG&#x000a0;<sup>2</sup></td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">Premature termination</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.650G&#x0003e;A</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Arg217Gln</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/NM_000456.2">NM_000456.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.794C&#x0003e;A</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Ala265Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.1400C&#x0003e;G</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Tyr400Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">c.1589G&#x0003e;A</td>
                <td headers="hd_h_iso-def.T.selected_suox_pathogenic_varia_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">p.Gly530Asp</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
            <fn id="iso-def.TF.3.1">
              <label>1. </label>
              <p>The original publication does not use current naming conventions and the c. nomenclature could not be determined [<xref ref-type="bibr" rid="iso-def.REF.edwards.1999.1957">Edwards et al 1999</xref>].</p>
            </fn>
            <fn id="iso-def.TF.3.2">
              <label>2. </label>
              <p>The original publication does not use current naming conventions and names this variant c.1244delG [<xref ref-type="bibr" rid="iso-def.REF.seidahmed.2005.205">Seidahmed et al 2005</xref>].</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Sulfite oxidase is a molybdohemoprotein comprising 466 amino acids localized to the intermembrane space of mitochondria. The enzyme is a dimer of identical units consisting of three domains: an N-terminal heme domain, a central molybdenum domain, and a C-terminal domain. Sulfite oxidase catalyzes the oxidation of sulfite to sulfate, the terminal reaction in the pathway of degradation of the sulfur amino acids cysteine and methionine. The electrons derived from this reaction are transferred to cytochrome <italic toggle="yes">c</italic> on the mitochondrial inner membrane.</p>
        <p><bold>Abnormal gene product.</bold> The effects of pathogenic variants on sulfite oxidase structure that have been characterized in a few instances include: (1) conformational changes around the active site leading to perturbation of substrate binding and/or oxidation; (2) global effects on the stability and alteration of the sulfite oxidase dimer; and (3) defective molybdenum cofactor binding [<xref ref-type="bibr" rid="iso-def.REF.karakas.2005.3459">Karakas &#x00026; Kisker 2005</xref>].</p>
      </sec>
      <sec id="iso-def.References">
        <title>References</title>
        <sec id="iso-def.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="iso-def.Literature_Cited.reflist0">
            <ref id="iso-def.REF.basheer.2007.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Basheer</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Waters</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Acquaviva-Bourdain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poskitt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hukin</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <article-title>Isolated sulfite oxidase deficiency in the newborn: lactic acidaemia and leukoencephalopathy.</article-title>
                <source>Neuropediatrics.</source>
                <year>2007</year>
                <volume>38</volume>
                <fpage>38</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">17607604</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.bindu.2011.1036">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bindu</surname>
                    <given-names>PS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Christopher</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahadevan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bharath</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and imaging observations in isolated sulfite oxidase deficiency.</article-title>
                <source>J Child Neurol.</source>
                <year>2011</year>
                <volume>26</volume>
                <fpage>1036</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">21572056</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.bosley.2014.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alorainy</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oystreck</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellani</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidahmed</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osman Mel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabry</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Yamani</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Neurologic injury in isolated sulfite oxidase deficiency.</article-title>
                <source>Can J Neurol Sci.</source>
                <year>2014</year>
                <volume>41</volume>
                <fpage>42</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">24384336</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.chen.2014.181">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>LW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsai</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>CC</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal multicystic encephalopathy in isolated sulfite oxidase deficiency with a novel mutation.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2014</year>
                <volume>51</volume>
                <fpage>181</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">24938149</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.cho.2013.13">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goh</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lau</surname>
                    <given-names>KC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ong</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>CW</given-names>
                  </name>
                </person-group>
                <article-title>Microarray analysis unmasked paternal uniparental disomy of chromosome 12 in a patient with isolated sulfite oxidase deficiency.</article-title>
                <source>Clin Chim Acta.</source>
                <year>2013</year>
                <volume>426</volume>
                <fpage>13</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">23994568</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.del_rizzo.2013.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Del Rizzo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beermann</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanco</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazzorla</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bordugo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giordano</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manara</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burlina</surname>
                    <given-names>AB</given-names>
                  </name>
                </person-group>
                <article-title>Metabolic stroke in a late-onset form of isolated sulfite oxidase deficiency.</article-title>
                <source>Mol Genet Metab.</source>
                <year>2013</year>
                <volume>108</volume>
                <fpage>263</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">23414711</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.edwards.1999.1957">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marriage</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graf</surname>
                    <given-names>TN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coyne</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>MacDonald</surname>
                    <given-names>IM</given-names>
                  </name>
                </person-group>
                <article-title>Isolated sulfite oxidase deficiency: review of two cases in one family.</article-title>
                <source>Ophthalmology.</source>
                <year>1999</year>
                <volume>106</volume>
                <fpage>1957</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">10519592</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.eichler.2006.801">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krishnamoorthy</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <article-title>Proton magnetic resonance spectroscopy and diffusion-weighted imaging in isolated sulfite oxidase deficiency.</article-title>
                <source>J Child Neurol.</source>
                <year>2006</year>
                <volume>21</volume>
                <fpage>801</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16970890</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.hoffmann.2007.1214">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoffmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Zeev</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anikster</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nissenkorn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuint</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kushnir</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <article-title>Magnetic resonance imaging and magnetic resonance spectroscopy in isolated sulfite oxidase deficiency.</article-title>
                <source>J Child Neurol.</source>
                <year>2007</year>
                <volume>22</volume>
                <fpage>1214</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">17940249</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.huang.2012.44">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huang</surname>
                    <given-names>JK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chiu</surname>
                    <given-names>NC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>CS</given-names>
                  </name>
                </person-group>
                <article-title>[99]mTc-ethyl cysteinate dimer cranial single-photon emission computed tomography and serial cranial magnetic resonance imaging in a girl with isolated sulfite oxidase deficiency.</article-title>
                <source>Pediatr Neurol.</source>
                <year>2012</year>
                <volume>47</volume>
                <fpage>44</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22704016</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.holder.2014.782">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holder</surname>
                    <given-names>JL</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Agadi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reese</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rehder</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quach</surname>
                    <given-names>MM</given-names>
                  </name>
                </person-group>
                <article-title>Infantile spasms and hyperekplexia associated with isolated sulfite oxidase deficiency.</article-title>
                <source>JAMA Neurol.</source>
                <year>2014</year>
                <volume>71</volume>
                <fpage>782</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">24756183</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.johnson.2001">
              <mixed-citation publication-type="book">Johnson JL, Duran M. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Vogelstein B, eds. <italic toggle="yes">The Metabolic and Molecular Bases of Inherited Disease</italic>. Vol 2. 8 ed. New York, NY: McGraw-Hill; 2001:3163-77.</mixed-citation>
            </ref>
            <ref id="iso-def.REF.karakas.2005.3459">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Karakas</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kisker</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Structural analysis of missense mutations causing isolated sulfite oxidase deficiency.</article-title>
                <source>Dalton Trans.</source>
                <year>2005</year>
                <volume>21</volume>
                <fpage>3459</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16234925</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.lueder.1995.334">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lueder</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steiner</surname>
                    <given-names>RD</given-names>
                  </name>
                </person-group>
                <article-title>Ophthalmic abnormalities in molybdenum cofactor deficiency and isolated sulfite oxidase deficiency.</article-title>
                <source>J Pediatr Ophthalmol Strabismus.</source>
                <year>1995</year>
                <volume>32</volume>
                <fpage>334</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8531042</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.rashed.2005.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saadallah</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rahbeeni</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eyaid</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seidahmed</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Shahwan</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osman</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Amoudi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Ahaidib</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacob</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <article-title>Determination of urinary S-sulphocysteine, xanthine and hypoxanthine by liquid chromatography-electrospray tandem mass spectrometry.</article-title>
                <source>Biomed Chromatogr.</source>
                <year>2005</year>
                <volume>19</volume>
                <fpage>223</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">15558695</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.relinque.2015.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Relinque</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bardallo</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Granero</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jim&#x000e9;nez</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luna</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Isolated sulfite oxidase deficiency.</article-title>
                <source>J Neonatal Perinatal Med.</source>
                <year>2015</year>
                <volume>8</volume>
                <fpage>53</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25758000</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.rocha.2014.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rocha</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferreira</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>AI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sequeira</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <article-title>Sulfite oxidase deficiency--an unusual late and mild presentation.</article-title>
                <source>Brain Dev.</source>
                <year>2014</year>
                <volume>36</volume>
                <fpage>176</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">23452914</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.rupar.1996.299">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rupar</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gillett</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gordon</surname>
                    <given-names>BA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramsay</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajagopalan</surname>
                    <given-names>KV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bacheyie</surname>
                    <given-names>GS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sellers</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Isolated sulfite oxidase deficiency.</article-title>
                <source>Neuropediatrics.</source>
                <year>1996</year>
                <volume>27</volume>
                <fpage>299</fpage>
                <lpage>304</lpage>
                <pub-id pub-id-type="pmid">9050047</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.salih.2013.109">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Salih</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bosley</surname>
                    <given-names>TM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alorainy</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabry</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Yamani</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Akoum</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohamed</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abu-Amero</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hellani</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <article-title>Preimplantation genetic diagnosis in isolated sulfite oxidase deficiency.</article-title>
                <source>Can J Neurol Sci.</source>
                <year>2013</year>
                <volume>40</volume>
                <fpage>109</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">23250141</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.sass.2010.544">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sass</surname>
                    <given-names>JO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gunduz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Araujo Rodrigues Funayama</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korkmaz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dantas Pinto</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tuysuz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yanasse Dos Santos</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taskiran</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de F&#x000e1;tima Turcato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reiss</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walter</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yalcinkaya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camelo</surname>
                    <given-names>JS</given-names>
                    <suffix>Junior</suffix>
                  </name>
                </person-group>
                <article-title>Functional deficiencies of sulfite oxidase: differential diagnoses in neonates presenting with intractable seizures and cystic encephalomalacia.</article-title>
                <source>Brain Dev.</source>
                <year>2010</year>
                <volume>32</volume>
                <fpage>544</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">19793632</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.seidahmed.2005.205">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seidahmed</surname>
                    <given-names>MZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alyamani</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rashed</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saadallah</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdelbasit</surname>
                    <given-names>OB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaheed</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rasheed</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamid</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sabry</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <article-title>Total truncation of the molybdopterin/dimerization domains of SUOX protein in an Arab family with isolated sulfite oxidase deficiency.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2005</year>
                <volume>136</volume>
                <fpage>205</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">15952210</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.tan.2005.757">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eichler</surname>
                    <given-names>FS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoda</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baris</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanley</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grant</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krishnamoorthy</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shih</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <article-title>Isolated sulfite oxidase deficiency: a case report with a novel mutation and review of the literature.</article-title>
                <source>Pediatrics.</source>
                <year>2005</year>
                <volume>116</volume>
                <fpage>757</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">16140720</pub-id>
              </element-citation>
            </ref>
            <ref id="iso-def.REF.van_der_knaap.2005">
              <mixed-citation publication-type="book">Van der Knaap MS, Valk J. Molybdenum cofactor deficiency and isolated sulfite oxidase deficiency. In: <italic toggle="yes">Magnetic Resonance Myelination and Myelin Disorders</italic>. 3 ed. Berlin-Heidelberg: Springer; 2005:372&#x02013;6.</mixed-citation>
            </ref>
            <ref id="iso-def.REF.volpe.2008">
              <mixed-citation publication-type="book">Volpe JJ. Hypoxic ischemic encephalopathy: clinical aspects. In: <italic toggle="yes">Neurology of the Newborn.</italic> 5 ed. Philadelphia: Saunders; 2008:400-80</mixed-citation>
            </ref>
            <ref id="iso-def.REF.zaki.2016.714">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zaki</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Selim</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Bassyouni</surname>
                    <given-names>HT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Issa</surname>
                    <given-names>MY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mahmoud</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ismail</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Girgis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadek</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gleeson</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abdel Hamid</surname>
                    <given-names>MS</given-names>
                  </name>
                </person-group>
                <article-title>Molybdenum cofactor and isolated sulphite oxidase deficiencies: clinical and molecular spectrum among Egyptian patients.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2016</year>
                <volume>20</volume>
                <fpage>714</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">27289259</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="iso-def.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="iso-def.Acknowledgments">
          <title>Acknowledgments</title>
          <p>The authors wish to thank all patients and their families for their collaboration.</p>
        </sec>
        <sec id="iso-def.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>21 September 2017 (bp) Review posted live</p>
            </list-item>
            <list-item>
              <p>27 March 2017 (psb) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="iso-def.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Two males of Indian origin with classic isolated sulfite oxidase deficiencya. Male child age 14 months (head circumference 43 cm; &#x0003c;5th centile for age); note long philtrum and thick lips. b. Male child age eight years with severe microcephaly (head circumference 45 cm; &#x0003c;5th centile for age); note puffy cheeks, narrow bifrontal diameter, elongated palpebral fissures, and long philtrum.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="iso-def-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="iso-def.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Brain MRI in a child with classic isolated sulfite oxidase deficiencya. T<sub>2</sub>-weighted axial view demonstrates cystic leukomalacia at age 29 days. b. Follow-up MRI at age eight months shows ventricular dilatation and diffuse ulegyria. c. T<sub>1</sub>-weighted sagittal view shows cerebellar hypoplasia and thin corpus callosum.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="iso-def-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
